Xiao Shen is the founder of Canton Biologics. Canton Biologics has raised $41M in total funding. Latest round: Series C. Based in Guangzhou, China.
Xiao Shen is the founder and CEO of Canton Biologics, a company established in Guangzhou in 2016. Canton Biologics specializes in large molecule biopharmaceutical CDMO services, offering end-to-end solutions from CMC development to commercial production and global clinical supply. Shen's leadership emphasizes 'reliability, efficiency, and innovation' in their operations.
Full founder directory · Investor directory · Company funding database · Fundraising library